The British Airline Pilots’ Association has worked with clinical toxicologists at Guy’s and St. Thomas’ NHS Foundation Trust, the Royal College of General Practitioners, the Civil Aviation Authority, easyJet and academia to create a care pathway for patients presenting with possible cabin air-related symptoms, which can include itching or soreness of the eyes, nasal discharge, sore throat or coughing.
In recent years, concerns have been raised about possible long-term adverse health effects of exposure to contaminants in cabin air.
BALPA says it’s important to have a clear pathway in place. As the problem is complex, some cases may require medical specialists to assess them correctly.
BALPA Head of Flight Safety, Dr Rob Hunter, said:
“Care pathways are approved by authoritative medical bodies and represent the best use of NHS resources.
“Although the vast majority of fume events do not lead to crew and passengers requiring treatment, we want to ensure the proper processes are put in place for those who do.
“Working with our partners we feel this new pathway will enable doctors to take the appropriate steps to ensure the affected person gets the best treatment.
“We believe until now, there has been a lot of confusing information and pilots have been unsure as to who they should see if they have persisting symptoms.
“BALPA hopes that the work we’ve done in this area will give pilots a clearer understanding of who is best to treat them.
“We also hope that use of the pathway will facilitate further research, which would be led by the centre of excellence at the Clinical Toxicology Unit of Guy’s and St Thomas’ Hospital, in understanding the possible health effects of contaminated cabin air.”
News source: atn.aero